-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Upgrades BioNTech to Buy, Raises Price Target to $142

Benzinga·01/16/2026 11:56:07
Listen to the news
Goldman Sachs analyst Asad Haider upgrades BioNTech (NASDAQ:BNTX) from Neutral to Buy and raises the price target from $115 to $142.